Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06575270 · ClinicalTrials.gov registry record
Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)
A clinical trial of Congenital Heart Disease and Hypoxemia, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- 92
- Enrollment target
- 1
- Study location
NCT06575270 is a study of Congenital Heart Disease and Hypoxemia that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 92 participants, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06575270, a study of Congenital Heart Disease and Hypoxemia, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
Recent retrospective studies have demonstrated differences between pulse oximeter values (SpO2) and measured arterial oxygen saturation (SaO2) in patients identifying as Black or Hispanic. These retrospective studies have limitations because self-reported race is likely not an accurate metric for level of skin pigmentation and the retrospective nature of these studies may impact the accuracy of simultaneous measures of arterial oxygen saturation and pulse oximeter values. The few prospective studies that have evaluated this issue have utilized color-matching techniques to quantify skin pigmentation, and fewer studies have directly measured skin pigmentation in relation it to pulse oximeter accuracy. The aim of this study is to prospectively measure pulse oximeter accuracy in relation to measured levels of skin pigmentation in the congenital heart disease population.
Conditions Studied
Study Locations (1)
New York
- Mount Sinai Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2024-10-29 |
| Est. Completion | 2026-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06575270
The ClinicalTrials.gov registry entry for NCT06575270 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (81% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 0 interventions.
NCT06575270 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06575270 about?
NCT06575270 is a clinical study titled "Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)". Recent retrospective studies have demonstrated differences between pulse oximeter values (SpO2) and measured arterial oxygen saturation (SaO2) in patients identifying as Black or Hispanic. These retrospective studies have limitations because self-reported race is likely not an accurate metric for le...
What is the current status of trial NCT06575270?
This trial is currently recruiting. The enrollment target is 92 participants. The study started on 2024-10-29. Estimated completion is 2026-07.
What conditions does trial NCT06575270 study?
This clinical trial studies the following conditions: Congenital Heart Disease, Hypoxemia, Skin Pigment.
Who is sponsoring clinical trial NCT06575270?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06575270 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fontan Fitness Trial
RECRUITING · NA
-
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
RECRUITING
-
A Study of Invasive Hemodynamic for MACHD Registry
RECRUITING
-
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
RECRUITING
-
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
RECRUITING
-
PDA for Kidneys Study
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.